slotkoers
Shenzhen S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
4,05
CNY
|
-5,15%
|
|
+2,02%
|
-47,67%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.270
|
2.547
|
4.299
|
5.325
|
3.416
|
2.712
|
Bedrijfswaarde
1 |
2.187
|
2.372
|
5.151
|
6.168
|
4.418
|
3.534
|
K/w-verhouding
|
22
x
|
-3,81
x
|
170
x
|
108
x
|
-147
x
|
-4,48
x
|
Dividendrendement
|
0,51%
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,58
x
|
3,51
x
|
3,54
x
|
2,25
x
|
2,11
x
|
2,26
x
|
Bedrijfswaarde/omzet
|
2,48
x
|
3,27
x
|
4,24
x
|
2,61
x
|
2,73
x
|
2,95
x
|
Bedrijfswaarde/EBITDA
|
13,9
x
|
-58,2
x
|
43,2
x
|
21,6
x
|
24,7
x
|
30,5
x
|
Bedrijfswaarde/FCF
|
-8,02
x
|
16,9
x
|
21,2
x
|
-15
x
|
-14,4
x
|
8,83
x
|
FCF Yield
|
-12,5%
|
5,91%
|
4,72%
|
-6,67%
|
-6,92%
|
11,3%
|
Price to Book
|
1,58
x
|
3,36
x
|
5,53
x
|
6,44
x
|
4,27
x
|
13,9
x
|
Aantal aandelen (in duizenden)
|
350.336
|
350.336
|
350.336
|
350.336
|
350.336
|
350.336
|
Referentieprijs
2 |
6,480
|
7,270
|
12,27
|
15,20
|
9,750
|
7,740
|
Datum van publicatie
|
29/03/19
|
27/04/20
|
27/04/21
|
27/04/22
|
27/04/23
|
29/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
881
|
725,3
|
1.215
|
2.362
|
1.615
|
1.198
|
EBITDA
1 |
156,8
|
-40,72
|
119,4
|
285,2
|
178,9
|
115,7
|
Bedrijfsresultaat (EBIT)
1 |
116,1
|
-81,4
|
78,76
|
228,6
|
75,5
|
79,14
|
Operationele Marge
|
13,17%
|
-11,22%
|
6,49%
|
9,68%
|
4,67%
|
6,61%
|
Resultaat voor belastingen (EBT)
1 |
116,5
|
-680,2
|
58,41
|
158,3
|
71,83
|
-681
|
Nettowinst (verlies)
1 |
102
|
-669,7
|
25,32
|
49,1
|
-23,27
|
-605,7
|
Nettomarge
|
11,58%
|
-92,33%
|
2,08%
|
2,08%
|
-1,44%
|
-50,57%
|
WPA
2 |
0,2949
|
-1,910
|
0,0723
|
0,1402
|
-0,0664
|
-1,729
|
Free Cash Flow
1 |
-272,6
|
140,2
|
243,3
|
-411,3
|
-305,8
|
400,3
|
FCF-marge
|
-30,94%
|
19,32%
|
20,04%
|
-17,41%
|
-18,93%
|
33,42%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
203,87%
|
-
|
-
|
345,83%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
961,02%
|
-
|
-
|
-
|
Dividend per aandeel
2 |
0,0333
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/03/19
|
27/04/20
|
27/04/21
|
27/04/22
|
27/04/23
|
29/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
852
|
843
|
1.002
|
822
|
Nettokaspositie
1 |
83,1
|
175
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
7,141
x
|
2,957
x
|
5,601
x
|
7,105
x
|
Free Cash Flow
1 |
-273
|
140
|
243
|
-411
|
-306
|
400
|
ROE (netto-inkomsten/eigen vermogen)
|
8,42%
|
-61,6%
|
6,02%
|
10,4%
|
2,72%
|
-52,7%
|
ROA (netto-inkomsten/totale activa)
|
3,58%
|
-2,82%
|
1,59%
|
3,21%
|
1,21%
|
1,41%
|
Totale activa
1 |
2.850
|
23.742
|
1.596
|
1.529
|
-1.922
|
-43.006
|
Nettoactief per aandeel
2 |
4,100
|
2,160
|
2,220
|
2,360
|
2,290
|
0,5600
|
Cashflow per aandeel
2 |
1,020
|
1,170
|
0,4000
|
0,3100
|
0,0500
|
0,0400
|
Capex
1 |
8,84
|
5,24
|
18,8
|
142
|
51,5
|
6,79
|
Capex/omzet
|
1%
|
0,72%
|
1,55%
|
6,02%
|
3,19%
|
0,57%
|
Datum van publicatie
|
29/03/19
|
27/04/20
|
27/04/21
|
27/04/22
|
27/04/23
|
29/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -47,67% | 196 mln. | | +26,08% | 662 mld. | | +21,85% | 546 mld. | | -4,77% | 359 mld. | | +16,97% | 323 mld. | | +5,69% | 290 mld. | | +13,68% | 234 mld. | | +3,65% | 198 mld. | | -11,12% | 194 mld. | | +8,08% | 167 mld. |
Farmaceutische producten - Andere
|